Folgen
Robert Widdop
Robert Widdop
Head of Dept Pharmacology, Monash University
Bestätigte E-Mail-Adresse bei monash.edu
Titel
Zitiert von
Zitiert von
Jahr
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
S Bosnyak, ES Jones, A Christopoulos, MI Aguilar, WG Thomas, ...
Clinical science 121 (7), 297-303, 2011
3042011
Nitroxyl (HNO): the Cinderella of the nitric oxide story
JC Irvine, RH Ritchie, JL Favaloro, KL Andrews, RE Widdop, ...
Trends in Pharmacological Sciences 29 (12), 601-608, 2008
3012008
AT2 receptors: functional relevance in cardiovascular disease
ES Jones, A Vinh, CA McCarthy, TA Gaspari, RE Widdop
Pharmacology & therapeutics 120 (3), 292-316, 2008
2902008
Angiotensin AT2 receptors: cardiovascular hope or hype?
RE Widdop, ES Jones, RE Hannan, TA Gaspari
British journal of pharmacology 140 (5), 809, 2003
2832003
Angiotensin-(1–7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats
PE Walters, TA Gaspari, RE Widdop
Hypertension 45 (5), 960-966, 2005
2532005
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
T Gaspari, HB Liu, I Welungoda, Y Hu, RE Widdop, LB Knudsen, ...
Diabetes and Vascular Disease Research 8 (2), 117-124, 2011
2262011
Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a
IR Chassagnon, CA McCarthy, YKY Chin, SS Pineda, A Keramidas, ...
Proceedings of the National Academy of Sciences 114 (14), 3750-3755, 2017
1942017
AT2 Receptor Stimulation Enhances Antihypertensive Effect of AT1 Receptor Antagonist in Hypertensive Rats
MN Barber, DB Sampey, RE Widdop
Hypertension 34 (5), 1112-1116, 1999
1881999
AT2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT1 Receptor Blockade
RE Widdop, K Matrougui, BI Levy, D Henrion
Hypertension 40 (4), 516-520, 2002
1852002
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E–Deficient mice
S Tesanovic, A Vinh, TA Gaspari, D Casley, RE Widdop
Arteriosclerosis, thrombosis, and vascular biology 30 (8), 1606-1613, 2010
1812010
Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats
AK Sampson, KM Moritz, ES Jones, RL Flower, RE Widdop, KM Denton
Hypertension 52 (4), 666-671, 2008
1752008
The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
T Gaspari, I Welungoda, RE Widdop, RW Simpson, AE Dear
Diabetes and Vascular Disease Research 10 (4), 353-360, 2013
1692013
Stimulation of angiotensin AT2 receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats
S Bosnyak, IK Welungoda, A Hallberg, M Alterman, RE Widdop, ES Jones
British journal of pharmacology 159 (3), 709-716, 2010
1672010
Restraint stress: differential cardiovascular responses in Wistar-Kyoto and spontaneously hypertensive rats
SJ McDougall, JRA Paull, RE Widdop, AJ Lawrence
Hypertension 35 (1), 126-129, 2000
1432000
Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice
CT Chan, JP Moore, K Budzyn, E Guida, H Diep, A Vinh, ES Jones, ...
Hypertension 60 (5), 1207-1212, 2012
1322012
Gender differences in pressure-natriuresis and renal autoregulation: role of the angiotensin type 2 receptor
LM Hilliard, M Nematbakhsh, MM Kett, E Teichman, AK Sampson, ...
Hypertension 57 (2), 275-282, 2011
1282011
Nitroxyl anion donor, Angeli’s salt, does not develop tolerance in rat isolated aortae
JC Irvine, JL Favaloro, RE Widdop, BK Kemp-Harper
Hypertension 49 (4), 885-892, 2007
1272007
Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke
CA McCarthy, A Vinh, JK Callaway, RE Widdop
Stroke 40 (4), 1482-1489, 2009
1252009
Non-peptide AT2-receptor agonists
UM Steckelings, M Larhed, A Hallberg, RE Widdop, ES Jones, ...
Current opinion in pharmacology 11 (2), 187-192, 2011
1242011
High blood pressure reduction reverses angiotensin II type 2 receptor–mediated vasoconstriction into vasodilation in spontaneously hypertensive rats
D You, L Loufrani, C Baron, BI Levy, RE Widdop, D Henrion
Circulation 111 (8), 1006-1011, 2005
1242005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20